CDKN2A and hepatocellular carcinoma: We developed a CRGs-score prognostic model including these five prognostic biomarkers (CDKN2A, DLAT, GLS, LIPT1, and MTF1), which showed a good effectiveness in predicting the survival outcome in HCC cohort.